Compile Data Set for Download or QSAR
maximum 50k data
Found 91 of ec50 data for polymerid = 816,50007623
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427204(US10544141, Compound 264)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427487(US10544141, Compound 546)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427488(US10544141, Compound 336)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427490(US10544141, Compound 337)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427491(US10544141, Compound 548)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427492(US10544141, Compound 338)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427494(US10544141, Compound 861)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427495(US10544141, Compound 554)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427497(US10544141, Compound 927)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427497(US10544141, Compound 927)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427498(US10544141, Compound 928)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427498(US10544141, Compound 928)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427499(US10544141, Compound 929)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427499(US10544141, Compound 929)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427500(US10544141, Compound 930)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427500(US10544141, Compound 930)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427501(US10544141, Compound 931)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427501(US10544141, Compound 931)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427502(US10544141, Compound 932)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427502(US10544141, Compound 932)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427503(US10544141, Compound 933)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427503(US10544141, Compound 933)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427504(US10544141, Compound 934)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427504(US10544141, Compound 934)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427505(US10544141, Compound 964)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427506(US10544141, Compound 965)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427506(US10544141, Compound 965)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427507(US10544141, Compound 966)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427508(US10544141, Compound 967)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427512(US10544141, Compound 971)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427519(US10544141, Compound 642)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427520(US10544141, Compound 782)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427522(US10544141, Compound 783)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427523(US10544141, Compound 693)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427525(US10544141, Compound 784)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427526(US10544141, Compound 694)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427527(US10544141, Compound 785)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427529(US10544141, Compound 786)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427531(US10544141, Compound 787)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427533(US10544141, Compound 788)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427535(US10544141, Compound 789)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427536(US10544141, Compound 662)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427537(US10544141, Compound 790)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427538(US10544141, Compound 663)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427539(US10544141, Compound 791)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427542(US10544141, Compound 665)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427546(US10544141, Compound 762)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427547(US10544141, Compound 744)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427548(US10544141, Compound 763)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427549(US10544141, Compound 757)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 91 total ) | Next | Last >>
Jump to: